GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

COSCIENS Biopharma CSCI.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

8.40

-1.18%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

COSCIENS Biopharma — daily TSX:CSCI Delayed
Market value
C$26.6m
Last close × shares
Volume
309
Shares, 9 Nov 2026

About COSCIENS Biopharma

Its shares trade on Toronto Stock Exchange under the ticker CSCI.TO. It has been listed since 19 December 1995. In the fiscal year to 31 December 2025, it reported revenue of $7.5m and a net loss of $10.4m. At that date it held total assets of $21.4m and shareholders' equity of $3.8m.

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The company is headquartered in Summerville, South Carolina. The firm operates through the biopharmaceutical segment. The firm is engaged in drug development activities and in the promotion of products for others. The firm's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The firm focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The firm's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc.

Figures and description from our data supplier, not checked against the company's own report.

More about COSCIENS Biopharma →

Latest on COSCIENS Biopharma

Our reporting

We have not reported on COSCIENS Biopharma yet.

Next results

10 Nov 2026

Due on 10 Nov 2026. Analysts expect earnings of -2.54 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is COSCIENS Biopharma's ticker?

COSCIENS Biopharma trades as CSCI.TO on Toronto Stock Exchange, under ISIN CA22112H1010.

What was COSCIENS Biopharma's last closing price?

8.40 on 9 Nov 2026. The figure is in CAD and is never converted.

When does COSCIENS Biopharma next report results?

Results are expected on 10 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.